{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,4]],"date-time":"2026-06-04T11:19:39Z","timestamp":1780571979197,"version":"3.54.1"},"reference-count":52,"publisher":"Wiley","issue":"4","license":[{"start":{"date-parts":[[2024,9,24]],"date-time":"2024-09-24T00:00:00Z","timestamp":1727136000000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100004329","name":"Javna Agencija za Raziskovalno Dejavnost RS","doi-asserted-by":"publisher","award":["P3\u201000083"],"award-info":[{"award-number":["P3\u201000083"]}],"id":[{"id":"10.13039\/501100004329","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100010661","name":"Horizon 2020 Framework Programme","doi-asserted-by":"publisher","award":["847845"],"award-info":[{"award-number":["847845"]}],"id":[{"id":"10.13039\/100010661","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["onlinelibrary.wiley.com"],"crossmark-restriction":true},"short-container-title":["Intl Journal of Cancer"],"published-print":{"date-parts":[[2025,2,15]]},"abstract":"<jats:title>Abstract<\/jats:title><jats:p>Molecular testing for human papillomaviruses (HPV) is gradually replacing cytology in cervical cancer screening. In this longitudinal population\u2010based cohort study, 4140 women 20 to 64\u2009years old attending organized screening were tested at baseline by five different screening methods and followed for 9\u2009years. To assess long\u2010term safety, the cumulative risks of CIN2+\/CIN3+ were estimated after a negative baseline result obtained by conventional cytology and four clinically validated HPV assays: Hybrid Capture 2 (hc2), RealTime High Risk HPV assay (RealTime), cobas 4800 HPV Test (cobas_4800), and Alinity m HR HPV (Alinity). HPV\u2010negative women at baseline had a substantially lower risk for CIN2+ compared to those with normal baseline cytology: 0.84% (95% CI, 0.46\u20131.22), 0.90% (95% CI, 0.51\u20131.29), 0.78% (95% CI, 0.42\u20131.15), and 0.75% (95% CI, 0.39\u20131.11) for hc2, RealTime, cobas_4800, and Alinity, respectively, compared to 2.46% (95% CI, 1.88\u20133.03) for cytology. No differences were observed between HPV assays in longitudinal sensitivity (range: 86.21%\u201390.36%) and negative predictive values (range: 99.54%\u201399.70%) for CIN2+ in women \u226530\u2009years, but were significantly different from cytology (<jats:italic>p<\/jats:italic>\u2009&lt;\u2009.05). The 9\u2010year cumulative risk of CIN2+ differed significantly between HPV genotypes, reaching 32.1% (95% CI, 14.5\u201346.1) for HPV16, 24.9% (95% CI, 4.7\u201340.8) for HPV18\/45, 27.2% (95% CI, 14.6\u201337.8) for HPV31\/33\/35\/52\/58, and 8.1% (95% CI, 0.0\u201316.7) for HPV39\/51\/56\/59. Four clinically validated HPV assays showed comparable safety and better assurance against precancerous lesions than cytology, but some important differences were identified in the performance characteristics of HPV assays impacting the referral rate. Information about the HPV genotype is valuable for guiding further clinical action in HPV\u2010based screening programs.<\/jats:p>","DOI":"10.1002\/ijc.35200","type":"journal-article","created":{"date-parts":[[2024,9,24]],"date-time":"2024-09-24T13:22:17Z","timestamp":1727184137000},"page":"788-801","update-policy":"https:\/\/doi.org\/10.1002\/crossmark_policy","source":"Crossref","is-referenced-by-count":8,"title":["Clinically validated <scp>HPV<\/scp> assays offer comparable long\u2010term safety in primary cervical cancer screening: A 9\u2010year follow\u2010up of a population\u2010based screening cohort"],"prefix":"10.1002","volume":"156","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-3061-5319","authenticated-orcid":false,"given":"Anja","family":"O\u0161trbenk Valen\u010dak","sequence":"first","affiliation":[{"name":"Institute of Microbiology and Immunology, Faculty of Medicine University of Ljubljana  Ljubljana Slovenia"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0005-7546-4410","authenticated-orcid":false,"given":"Kelsi R.","family":"Kroon","sequence":"additional","affiliation":[{"name":"Department of Epidemiology and Data Science, Amsterdam UMC VU University Amsterdam  Amsterdam Netherlands"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Danijela","family":"Fabjan","sequence":"additional","affiliation":[{"name":"Institute of Microbiology and Immunology, Faculty of Medicine University of Ljubljana  Ljubljana Slovenia"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jana","family":"Mlakar","sequence":"additional","affiliation":[{"name":"Institute of Microbiology and Immunology, Faculty of Medicine University of Ljubljana  Ljubljana Slovenia"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Katja","family":"Seme","sequence":"additional","affiliation":[{"name":"Institute of Microbiology and Immunology, Faculty of Medicine University of Ljubljana  Ljubljana Slovenia"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Johannes","family":"Berkhof","sequence":"additional","affiliation":[{"name":"Department of Epidemiology and Data Science, Amsterdam UMC VU University Amsterdam  Amsterdam Netherlands"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mario","family":"Poljak","sequence":"additional","affiliation":[{"name":"Institute of Microbiology and Immunology, Faculty of Medicine University of Ljubljana  Ljubljana Slovenia"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"311","published-online":{"date-parts":[[2024,9,24]]},"reference":[{"key":"e_1_2_11_2_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.vaccine.2012.06.095"},{"key":"e_1_2_11_3_1","doi-asserted-by":"publisher","DOI":"10.1093\/jnci\/dju153"},{"key":"e_1_2_11_4_1","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(13)62218-7"},{"key":"e_1_2_11_5_1","doi-asserted-by":"publisher","DOI":"10.1093\/jnci\/djj209"},{"key":"e_1_2_11_6_1","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa071430"},{"key":"e_1_2_11_7_1","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa073204"},{"key":"e_1_2_11_8_1","doi-asserted-by":"publisher","DOI":"10.1016\/S1470-2045(09)70156-1"},{"key":"e_1_2_11_9_1","doi-asserted-by":"publisher","DOI":"10.1093\/jnci\/djp367"},{"key":"e_1_2_11_10_1","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa0808516"},{"key":"e_1_2_11_11_1","doi-asserted-by":"publisher","DOI":"10.1016\/S1470-2045(09)70360-2"},{"key":"e_1_2_11_12_1","doi-asserted-by":"publisher","DOI":"10.1038\/bjc.2012.489"},{"key":"e_1_2_11_13_1","doi-asserted-by":"publisher","DOI":"10.1136\/bmj.g130"},{"key":"e_1_2_11_14_1","doi-asserted-by":"publisher","DOI":"10.1002\/ijc.23339"},{"key":"e_1_2_11_15_1","doi-asserted-by":"publisher","DOI":"10.1136\/bmj.a1754"},{"key":"e_1_2_11_16_1","doi-asserted-by":"publisher","DOI":"10.1016\/S1470-2045(11)70145-0"},{"key":"e_1_2_11_17_1","doi-asserted-by":"publisher","DOI":"10.1200\/JCO.2011.38.8389"},{"key":"e_1_2_11_18_1","doi-asserted-by":"publisher","DOI":"10.1158\/1940-6207.CAPR-14-0409"},{"key":"e_1_2_11_19_1","doi-asserted-by":"publisher","DOI":"10.1002\/ijc.29381"},{"key":"e_1_2_11_20_1","doi-asserted-by":"publisher","DOI":"10.1016\/S2214-109X(22)00241-8"},{"key":"e_1_2_11_21_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.jcv.2024.105671"},{"key":"e_1_2_11_22_1","doi-asserted-by":"publisher","DOI":"10.1002\/ijc.24010"},{"key":"e_1_2_11_23_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.cmi.2021.04.031"},{"issue":"511","key":"e_1_2_11_24_1","first-page":"e1","article-title":"Long\u2010term cervical precancer outcomes after a negative DNA\u2010 or RNA\u2010based human papillomavirus test result","volume":"225","author":"Strang THR","year":"2021","journal-title":"Am J Obstet Gynecol"},{"key":"e_1_2_11_25_1","doi-asserted-by":"publisher","DOI":"10.7326\/M17-1609"},{"key":"e_1_2_11_26_1","doi-asserted-by":"publisher","DOI":"10.1002\/ijc.30385"},{"key":"e_1_2_11_27_1","doi-asserted-by":"publisher","DOI":"10.1136\/bmj.i4924"},{"key":"e_1_2_11_28_1","doi-asserted-by":"publisher","DOI":"10.1158\/1055-9965.EPI-20-1177"},{"key":"e_1_2_11_29_1","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pmed.1004115"},{"key":"e_1_2_11_30_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.vaccine.2012.05.088"},{"key":"e_1_2_11_31_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.jcv.2015.11.015"},{"key":"e_1_2_11_32_1","doi-asserted-by":"publisher","DOI":"10.1002\/ijc.30375"},{"key":"e_1_2_11_33_1","doi-asserted-by":"publisher","DOI":"10.1097\/LGT.0000000000000494"},{"key":"e_1_2_11_34_1","doi-asserted-by":"publisher","DOI":"10.1002\/ijc.32973"},{"key":"e_1_2_11_35_1","doi-asserted-by":"publisher","DOI":"10.1186\/s12885-021-09126-3"},{"key":"e_1_2_11_36_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.ygyno.2023.04.022"},{"key":"e_1_2_11_37_1","doi-asserted-by":"publisher","DOI":"10.1128\/JCM.00012-11"},{"key":"e_1_2_11_38_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.jcv.2015.11.021"},{"key":"e_1_2_11_39_1","doi-asserted-by":"publisher","DOI":"10.1007\/BF02295996"},{"key":"e_1_2_11_40_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.jclinepi.2012.09.018"},{"key":"e_1_2_11_41_1","first-page":"1","article-title":"Cervical cancer screening","volume":"18","author":"International Agency for Research on Cancer (IARC)","year":"2022","journal-title":"IARC Handb Cancer Prev"},{"key":"e_1_2_11_42_1","doi-asserted-by":"publisher","DOI":"10.1002\/ijc.29019"},{"key":"e_1_2_11_43_1","volume-title":"Target Product Profiles. Global Observatory on Health R&D","author":"World Health Organization","year":"2024"},{"key":"e_1_2_11_44_1","doi-asserted-by":"publisher","DOI":"10.3310\/hta23280"},{"key":"e_1_2_11_45_1","doi-asserted-by":"publisher","DOI":"10.1128\/JCM.01177-18"},{"key":"e_1_2_11_46_1","doi-asserted-by":"crossref","DOI":"10.1136\/bmj-2021-068776","article-title":"Extension of cervical screening intervals with primary human papillomavirus testing: observational study of English screening pilot data","volume":"377","author":"Rebolj M","year":"2022","journal-title":"BMJ"},{"key":"e_1_2_11_47_1","doi-asserted-by":"publisher","DOI":"10.1038\/sj.bjc.6602541"},{"key":"e_1_2_11_48_1","doi-asserted-by":"publisher","DOI":"10.1016\/S1386-6532(02)00187-7"},{"key":"e_1_2_11_49_1","doi-asserted-by":"publisher","DOI":"10.1128\/JCM.00824-08"},{"key":"e_1_2_11_50_1","doi-asserted-by":"publisher","DOI":"10.1128\/JCM.00278-09"},{"key":"e_1_2_11_51_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.jcv.2023.105581"},{"key":"e_1_2_11_52_1","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0086835"},{"key":"e_1_2_11_53_1","doi-asserted-by":"publisher","DOI":"10.1002\/ijc.29085"}],"container-title":["International Journal of Cancer"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/pdf\/10.1002\/ijc.35200","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,12,20]],"date-time":"2024-12-20T16:26:59Z","timestamp":1734712019000},"score":1,"resource":{"primary":{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/10.1002\/ijc.35200"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,9,24]]},"references-count":52,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2025,2,15]]}},"alternative-id":["10.1002\/ijc.35200"],"URL":"https:\/\/doi.org\/10.1002\/ijc.35200","archive":["Portico"],"relation":{},"ISSN":["0020-7136","1097-0215"],"issn-type":[{"value":"0020-7136","type":"print"},{"value":"1097-0215","type":"electronic"}],"subject":[],"published":{"date-parts":[[2024,9,24]]},"assertion":[{"value":"2024-06-26","order":0,"name":"received","label":"Received","group":{"name":"publication_history","label":"Publication History"}},{"value":"2024-09-12","order":2,"name":"accepted","label":"Accepted","group":{"name":"publication_history","label":"Publication History"}},{"value":"2024-09-24","order":3,"name":"published","label":"Published","group":{"name":"publication_history","label":"Publication History"}}]}}